BRIEF-Valeant Pharmaceuticals enter amendment, waiver to third amended,restated agreement
April 11 (Reuters) - Valeant Pharmaceuticals International Inc
* Entered into amendment and waiver to third amended,restated credit,guaranty agreement, dated as of feb 13, 2012
* Amendment extends deadline for filing company's form 10-k for fiscal year ended dec. 31, 2015 to may 31, 2016
* Amendment also permits company to incur up to $750 million of additional unsecured indebtedness at any time
* Amendment modifies add-backs to consolidated adjusted ebitda under credit agreement Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.